Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Oncogenesis is associated with intestinal dysbiosis, and stool shotgun metagenomic
sequencing in individuals with this condition might constitute a non-invasive approach for …
sequencing in individuals with this condition might constitute a non-invasive approach for …
COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options
LE van Eijk, M Binkhorst, AR Bourgonje… - The Journal of …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide …
syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide …
[HTML][HTML] Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects
G Lisco, A De Tullio, E Jirillo, VA Giagulli… - Journal of …, 2021 - Springer
Background Thyroid dysfunction has been observed in patients with COVID-19, and
endocrinologists are requested to understand this clinical issue. Pandemic-related …
endocrinologists are requested to understand this clinical issue. Pandemic-related …
[HTML][HTML] COVID-19 vaccination and breakthrough infections in patients with cancer
Background Vaccination is an important preventive health measure to protect against
symptomatic and severe COVID-19. Impaired immunity secondary to an underlying …
symptomatic and severe COVID-19. Impaired immunity secondary to an underlying …
Association of COVID-19 with comorbidities: An update
S Chatterjee, LV Nalla, M Sharma… - ACS Pharmacology & …, 2023 - ACS Publications
Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2) which was identified in Wuhan, China in December 2019 and …
coronavirus-2 (SARS-CoV-2) which was identified in Wuhan, China in December 2019 and …
[HTML][HTML] Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma
A Keppler-Hafkemeyer, C Greil, PR Wratil… - Nature Cancer, 2023 - nature.com
Individuals with hematologic malignancies are at increased risk for severe coronavirus
disease 2019 (COVID-19), yet profound analyses of COVID-19 vaccine-induced immunity …
disease 2019 (COVID-19), yet profound analyses of COVID-19 vaccine-induced immunity …
[HTML][HTML] The intersection of COVID-19 and cancer: signaling pathways and treatment implications
The outbreak of the novel coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a serious public health …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a serious public health …
[HTML][HTML] The impact of COVID-19 on comorbidities: a review of recent updates for combating it
JA Malik, S Ahmed, M Shinde, MHS Almermesh… - Saudi journal of …, 2022 - Elsevier
Coronavirus disease is caused by the SARS-CoV-2 virus. The virus first appeared in Wuhan
(China) in December 2019 and has spread globally. Till now, it affected 269 million people …
(China) in December 2019 and has spread globally. Till now, it affected 269 million people …
[HTML][HTML] COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic
AJX Lee, K Purshouse - British Journal of Cancer, 2021 - nature.com
The SARS-Cov-2 pandemic in 2020 has caused oncology teams around the world to adapt
their practice in the aim of protecting patients. Early evidence from China indicated that …
their practice in the aim of protecting patients. Early evidence from China indicated that …
[HTML][HTML] Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized …
SJ Thomas, JL Perez, SP Lockhart, S Hariharan… - Vaccine, 2022 - Elsevier
Introduction Individuals with an underlying malignancy have high risk of poor COVID-19
outcomes. In clinical trials, COVID-19 vaccines were safe and efficacious against infection …
outcomes. In clinical trials, COVID-19 vaccines were safe and efficacious against infection …